{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:56Z","timestamp":1791277916612,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T00:00:00Z","timestamp":1293148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/leu.2010.287","type":"journal-article","created":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T11:39:04Z","timestamp":1293190744000},"page":"463-472","source":"Crossref","is-referenced-by-count":83,"title":["Janus kinase 2 regulates Bcr\u2013Abl signaling in chronic myeloid leukemia"],"prefix":"10.1038","volume":"25","author":[{"given":"A","family":"Samanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Perazzona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Priebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Arlinghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,24]]},"reference":[{"key":"BFleu2010287_CR1","first-page":"3426","volume":"56","author":"J Wilson-Rawls","year":"1996","unstructured":"Wilson-Rawls J, Xie SH, Liu J, Laneuville P, Arlinghaus RB . P210 Bcr-Abl interacts with the interleukin-3 \u03b2c subunit and constitutively induces its tyrosine phosphorylation. Cancer Res 1996; 56: 3426\u20133430.","journal-title":"Cancer Res"},{"key":"BFleu2010287_CR2","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","volume":"20","author":"S Xie","year":"2001","unstructured":"Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE et al. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene 2001; 20: 6188\u20136195.","journal-title":"Oncogene"},{"key":"BFleu2010287_CR3","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","volume":"21","author":"S Xie","year":"2002","unstructured":"Xie S, Lin H, Sun T, Arlinghaus RB . Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 2002; 21: 7137\u20137146.","journal-title":"Oncogene"},{"key":"BFleu2010287_CR4","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFleu2010287_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","volume":"13","author":"L Puil","year":"1994","unstructured":"Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG et al. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 1994; 13: 764\u2013773.","journal-title":"EMBO J"},{"key":"BFleu2010287_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","volume":"1","author":"M Sattler","year":"2002","unstructured":"Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. Critical role for Gab2 in transformation by BCR\/ABL. Cancer Cell 2002; 1: 479\u2013492.","journal-title":"Cancer Cell"},{"key":"BFleu2010287_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189\u2013218.","journal-title":"Leukemia"},{"key":"BFleu2010287_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","volume":"134","author":"P Coppo","year":"2006","unstructured":"Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML et al. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol 2006; 134: 171\u2013179.","journal-title":"Br J Haematol"},{"key":"BFleu2010287_CR9","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V93.12.4154","volume":"93","author":"RL Ilaria Jr","year":"1999","unstructured":"Ilaria Jr RL, Hawley RG, Van Etten RA . Dominant negative mutants implicate STAT 5 in myeloid cell proliferation and neutrophil differentiation. Blood 1999; 93: 4154\u20134166.","journal-title":"Blood"},{"key":"BFleu2010287_CR10","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","volume":"21","author":"A Klejman","year":"2002","unstructured":"Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE et al. The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells. EMBO J 2002; 21: 5766\u20135774.","journal-title":"EMBO J"},{"key":"BFleu2010287_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1128\/MCB.21.3.840-853.2001","volume":"21","author":"X Zhang","year":"2001","unstructured":"Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R . The NH (2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol 2001; 21: 840\u2013853.","journal-title":"Mol Cell Biol"},{"key":"BFleu2010287_CR12","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","volume":"67","author":"S Chu","year":"2007","unstructured":"Chu S, Li L, Singh H, Bhatia R . BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia. Cancer Res 2007; 67: 7045\u20137053.","journal-title":"Cancer Res"},{"key":"BFleu2010287_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876\u2013880.","journal-title":"Science"},{"key":"BFleu2010287_CR14","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1182\/blood-2004-03-1134","volume":"104","author":"S Branford","year":"2004","unstructured":"Branford S, Rudzki Z, Parkinson I, Grigg A, Taylor K, Seymour JF et al. Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations. Blood 2004; 104: 2926\u20132932.","journal-title":"Blood"},{"key":"BFleu2010287_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1034\/j.1600-0609.2000.065004258.x","volume":"65","author":"R Saffroy","year":"2000","unstructured":"Saffroy R, Lemoine A, Brezillon P, Frenoy N, Delmas B, Goldschmidt E et al. Real-time quantitation of bcr-abl transcripts in haematological malignancies. Eur J Haematol 2000; 65: 258\u2013266.","journal-title":"Eur J Haematol"},{"key":"BFleu2010287_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood.V101.2.690","volume":"101","author":"NJ Donato","year":"2003","unstructured":"Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R et al. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood 2003; 101: 690\u2013698.","journal-title":"Blood"},{"key":"BFleu2010287_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/0008-5472.CAN-03-1484","volume":"64","author":"NJ Donato","year":"2004","unstructured":"Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB et al. Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res 2004; 64: 672\u2013677.","journal-title":"Cancer Res"},{"key":"BFleu2010287_CR18","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1038\/sj.onc.1210979","volume":"27","author":"WJ Tao","year":"2008","unstructured":"Tao WJ, Lin H, Sun T, Samanta AK, Arlinghaus R . BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor. Oncogene 2008; 27: 3194\u20133200.","journal-title":"Oncogene"},{"key":"BFleu2010287_CR19","first-page":"854","volume":"114","author":"W Tao","year":"2009","unstructured":"Tao W, Samanta AK, Priebe W, Arlinghaus RB . Enhanced Jak2 activation correlates with IL-3 receptor \u03b2 Chain expression leading to phosphorylation of tyrosine 177 of Bcr-Abl. Blood (51th Am Soc Hematol Annu Meet Abst) 2009; 114: 854 (abstract 2170).","journal-title":"Blood (51th Am Soc Hematol Annu Meet Abst)"},{"key":"BFleu2010287_CR20","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","volume":"66","author":"AK Samanta","year":"2006","unstructured":"Samanta AK, Lin H, Sun T, Kantarjian H, Arlinghaus RB . Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res 2006; 66: 6468\u20136472.","journal-title":"Cancer Res"},{"key":"BFleu2010287_CR21","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/onc.2009.7","volume":"28","author":"AK Samanta","year":"2009","unstructured":"Samanta AK, Chakraborty SN, Wang Y, Kantarjian H, Sun X, Hood J et al. Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene 2009; 28: 1669\u20131681.","journal-title":"Oncogene"},{"key":"BFleu2010287_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/1947601910372232","volume":"1","author":"AK Samanta","year":"2010","unstructured":"Samanta AK, Chakraborty SN, Wang Y, Schlette E, Reddy EP, Arlinghaus RB . Destabilization of Bcr-Abl\/Jak2 Network by a Jak2\/Abl kinase inhibitor ON044580 overcomes drug resistance in blast crisis chronic myelogenous leukemia (CML). Genes Cancer 2010; 1: 346\u2013359.","journal-title":"Genes Cancer"},{"key":"BFleu2010287_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4161\/cc.8.9.8209","volume":"8","author":"SA Stuart","year":"2009","unstructured":"Stuart SA, Minami Y, Wang JY . The CML stem cell: evolution of the progenitor. Cell Cycle 2009; 8: 1338\u20131343.","journal-title":"Cell Cycle"},{"key":"BFleu2010287_CR24","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1073\/pnas.0808303105","volume":"105","author":"Y Minami","year":"2008","unstructured":"Minami Y, Stuart SA, Ikawa T, Jiang Y, Banno A, Hunton IC et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci USA 2008; 105: 17967\u201317972.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 4","key":"BFleu2010287_CR25","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.3816\/CLM.2009.s.037","volume":"9","author":"E Nicholson","year":"2009","unstructured":"Nicholson E, Holyoake T . The chronic myeloid leukemia stem cell. Clin Lymphoma Myeloma 2009; 9 (Suppl 4): S376\u2013S381.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"BFleu2010287_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1182\/asheducation-2008.1.436","volume":"2008","author":"C. H. Jamieson","year":"2008","unstructured":"Jamieson CH . Chronic myeloid leukemia stem cells. Hematology Am Soc Hematol Educ Program 2008, 436\u2013442.","journal-title":"Hematology"},{"issue":"Pt 5","key":"BFleu2010287_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/BST0351347","volume":"35","author":"HG Jorgensen","year":"2007","unstructured":"Jorgensen HG, Holyoake TL . Characterization of cancer stem cells in chronic myeloid leukaemia. Biochem Soc Trans 2007; 35 (Pt 5): 1347\u20131351.","journal-title":"Biochem Soc Trans"},{"key":"BFleu2010287_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","volume":"134","author":"G Hansen","year":"2008","unstructured":"Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008; 134: 496\u2013507.","journal-title":"Cell"},{"key":"BFleu2010287_CR29","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1128\/MCB.17.5.2497","volume":"17","author":"J Feng","year":"1997","unstructured":"Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN . Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol 1997; 17: 2497\u20132501.","journal-title":"Mol Cell Biol"},{"key":"BFleu2010287_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jcb.20513","volume":"96","author":"HM Huang","year":"2005","unstructured":"Huang HM, Lin YL, Chen CH, Chang TW . Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba\/F3 pro-B cells. J Cell Biochem 2005; 96: 361\u2013375.","journal-title":"J Cell Biochem"},{"key":"BFleu2010287_CR31","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/MCB.24.11.4955-4967.2004","volume":"24","author":"LS Argetsinger","year":"2004","unstructured":"Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C . Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol Cell Biol 2004; 24: 4955\u20134967.","journal-title":"Mol Cell Biol"},{"key":"BFleu2010287_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1128\/MCB.16.3.998","volume":"16","author":"J Liu","year":"1996","unstructured":"Liu J, Wu Y, Ma GZ, Lu D, Haataja L, Heisterkamp N et al. Inhibition of Bcr serine kinase by tyrosine phosphorylation. Mol Cell Biol 1996; 16: 998\u20131005.","journal-title":"Mol Cell Biol"},{"key":"BFleu2010287_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.onc.1201524","volume":"16","author":"Y Wu","year":"1998","unstructured":"Wu Y, Liu J, Arlinghaus RB . Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine\/threonine kinase. Oncogene 1998; 16: 141\u2013146.","journal-title":"Oncogene"},{"key":"BFleu2010287_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0092-8674(91)90521-Y","volume":"67","author":"Y Maru","year":"1991","unstructured":"Maru Y, Witte ON . The BCR gene encodes a novel serine\/threonine kinase activity within a single exon. Cell 1991; 67: 459\u2013468.","journal-title":"Cell"},{"key":"BFleu2010287_CR35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","volume":"21","author":"A Pardanani","year":"2007","unstructured":"Pardanani A, Hood J, Lasho T, Levine RL, Martin MB, Noronha G et al. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations. Leukemia 2007; 21: 1658\u20131668.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2010287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010287","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:03:21Z","timestamp":1684433001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,24]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFleu2010287"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.287","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,24]]}}}